The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.
On the basis of application, the molecular biology kits & reagents and enzymes market is broadly categorized into cloning, epigenetic, sequencing, and PCR. Out of these, during 2012–2015, the PCR category led the market in terms of value, and it is expected to continue leading it during the forecast period, owing to the massive endowments for stem cell research and rising prevalence of infectious diseases in the elderly. PCR offers millions of copies of a particular part of DNA, thus, helping escalate the amount of useful DNA data for research.
Increasing life expectancy is one of the major causes of the rising geriatric population. The elderly need extensive care, owing to their longer recovery time, low immunity level, and susceptibility to chronic diseases, including cancer, neurological disorders, diabetes mellitus, and atherosclerosis. Due to the increasing prevalence of such diseases, the demand for therapies and diagnosis is rising, thereby leading to the growth of the molecular biology kits & reagents and enzymes market. According to the United Nations Department of Economic and Social Affairs, the number people aged 60 years or above is escalating at a significant rate.
This population is predicted to surge by 56.0% globally, i.e. from 901 million in 2015 to 1.4 billion by 2030 and more than double after 2015 to reach 2.1 billion by 2050. The surging elderly population in Germany, the U.S., China, and India is projected to create a high demand for molecular biology enzymes, kits and reagents, which, in turn, would result in the growth of the molecular biology kits and reagents and enzymes market.
Furthermore, due to the rapid growth in the number of people suffering from cancer and infectious diseases, the demand for such products is on the rise. The prevalence of acquired immune deficiency syndrome, hepatitis C, and healthcare-associated infections is expected to grow during the forecast period owing to poor lifestyle and lack of access to preventive care. In 2014, in the U.S., as per the American Cancer Society, nearly 484,340 new cases of cancer were registered in people aged 65 years and above.
Thus, the rising incidence of cancer and infectious diseases and surging geriatric population are contributing to the growth of the market.
Read more: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market
On the basis of application, the molecular biology kits & reagents and enzymes market is broadly categorized into cloning, epigenetic, sequencing, and PCR. Out of these, during 2012–2015, the PCR category led the market in terms of value, and it is expected to continue leading it during the forecast period, owing to the massive endowments for stem cell research and rising prevalence of infectious diseases in the elderly. PCR offers millions of copies of a particular part of DNA, thus, helping escalate the amount of useful DNA data for research.
 |
| To learn more about this report at: http://bit.ly/2TIuudm |
This population is predicted to surge by 56.0% globally, i.e. from 901 million in 2015 to 1.4 billion by 2030 and more than double after 2015 to reach 2.1 billion by 2050. The surging elderly population in Germany, the U.S., China, and India is projected to create a high demand for molecular biology enzymes, kits and reagents, which, in turn, would result in the growth of the molecular biology kits and reagents and enzymes market.
Furthermore, due to the rapid growth in the number of people suffering from cancer and infectious diseases, the demand for such products is on the rise. The prevalence of acquired immune deficiency syndrome, hepatitis C, and healthcare-associated infections is expected to grow during the forecast period owing to poor lifestyle and lack of access to preventive care. In 2014, in the U.S., as per the American Cancer Society, nearly 484,340 new cases of cancer were registered in people aged 65 years and above.
Thus, the rising incidence of cancer and infectious diseases and surging geriatric population are contributing to the growth of the market.
Read more: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market
